Filing Flows › Strata Critical Medical (SRTA) › Who owns the stock
Who owns Strata Critical Medical (SRTA) stock
134 funds reported Strata Critical Medical (SRTA) shares in their latest 13F filings, worth $293M in all. The largest holder is Third Point LLC ($26.4M). Last quarter 76 funds added to their stakes and 43 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Third Point LLC | 5,000,000 | $26.4M | unchanged | 2026-06-30 |
| Northern Right Capital Management, L.P. | 4,890,584 | $25.8M | increase | 2026-06-30 |
| BlackRock | 4,835,516 | $25.5M | increase | 2026-06-30 |
| First Eagle Investment Management, LLC | 4,629,228 | $24.4M | increase | 2026-06-30 |
| Vanguard Group | 3,633,537 | $17.5M | increase | 2025-12-31 |
| Royce & Associates LP | 3,132,933 | $16.5M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,885,319 | $15.2M | increase | 2026-06-30 |
| ARK Investment Management LLC | 2,730,855 | $14.4M | decrease | 2026-06-30 |
| Pillsbury Lake Capital LLC | 2,171,006 | $11.4M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 1,755,383 | $9.3M | increase | 2026-06-30 |
| Dimensional Fund Advisors LP | 1,738,623 | $9.2M | increase | 2026-06-30 |
| State Street | 1,524,390 | $8.0M | increase | 2026-06-30 |
| Uniplan Investment Counsel | 1,429,514 | $7.5M | increase | 2026-06-30 |
| Bank of New York Mellon | 1,141,035 | $6.0M | increase | 2026-06-30 |
| Sumitomo Mitsui Trust Group | 1,052,611 | $5.5M | decrease | 2026-06-30 |
Strata Critical Medical's latest quarter
Strata Critical Medical, Q3 2026: revenue $74.1M (+50% year over year), operating margin -5.2%, net loss $7.6M, operating cash flow $9.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most SRTA stock?
By the latest 13F filings: Third Point LLC ($26.4M); Northern Right Capital Management, L.P. ($25.8M); BlackRock ($25.5M); First Eagle Investment Management, LLC ($24.4M); Vanguard Group ($17.5M).
What is the short interest in SRTA?
4,538,023 shares were sold short at the 2026-10-15 settlement, 4.76% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.